Business Description

PMV Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US69353Y1038
Description
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.42 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.16 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26.1 | |||||
3-Year EPS without NRI Growth Rate | -25.7 | |||||
3-Year FCF Growth Rate | -30.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.35 | |||||
9-Day RSI | 41.31 | |||||
14-Day RSI | 42.45 | |||||
6-1 Month Momentum % | 45.53 | |||||
12-1 Month Momentum % | -37.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.63 | |||||
Quick Ratio | 16.63 | |||||
Cash Ratio | 16.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.6 | |||||
Shareholder Yield % | -0.54 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -30.08 | |||||
ROA % | -27.42 | |||||
ROIC % | -275.93 | |||||
ROC (Joel Greenblatt) % | -416.45 | |||||
ROCE % | -31.69 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.32 | |||||
Price-to-Tangible-Book | 1.32 | |||||
EV-to-EBIT | -1.64 | |||||
EV-to-EBITDA | -1.65 | |||||
EV-to-FCF | -2.09 | |||||
Price-to-Net-Current-Asset-Value | 1.73 | |||||
Price-to-Net-Cash | 1.77 | |||||
Earnings Yield (Greenblatt) % | -60.98 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PMVP
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PMV Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.63 | ||
Beta | 0.93 | ||
Volatility % | 52.72 | ||
14-Day RSI | 42.45 | ||
14-Day ATR ($) | 0.530601 | ||
20-Day SMA ($) | 6.65225 | ||
12-1 Month Momentum % | -37.86 | ||
52-Week Range ($) | 3.84 - 13.02 | ||
Shares Outstanding (Mil) | 48.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PMV Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PMV Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
PMV Pharmaceuticals Inc Frequently Asked Questions
What is PMV Pharmaceuticals Inc(PMVP)'s stock price today?
The current price of PMVP is $6.24. The 52 week high of PMVP is $13.02 and 52 week low is $3.84.
When is next earnings date of PMV Pharmaceuticals Inc(PMVP)?
The next earnings date of PMV Pharmaceuticals Inc(PMVP) is 2023-11-08 Est..
Does PMV Pharmaceuticals Inc(PMVP) pay dividends? If so, how much?
PMV Pharmaceuticals Inc(PMVP) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |